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Abstract
 
Pathogen attachment is a crucial early step in mucosal infections. This step is mediated by im-
portant virulence factors called adhesins. To exert these functions, adhesins are typically sur-
face-exposed, although, surprisingly, some are also released into the extracellular milieu, the
relevance of which has previously not been studied. To address the role of adhesin release in
pathogenesis, we used 
 
Bordetella pertussis
 
 as a model, since its major adhesin, filamentous he-
magglutinin (FHA), partitions between the bacterial surface and the extracellular milieu. FHA
release depends on its maturation by the specific 
 
B. pertussis
 
 protease SphB1. We constructed
SphB1-deficient mutants and found that they were strongly affected in their ability to colonize
the mouse respiratory tract, although they adhered even better to host cells in vitro than their
wild-type parent strain. The defect in colonization could be overcome by prior nasal instilla-
tion of purified FHA or by coinfection with FHA-releasing 
 
B. pertussis
 
 strains, but not with
SphB1-producing FHA-deficient strains, ruling out a nonspecific effect of SphB1. These results
indicate that the release of FHA is important for colonization, as it may facilitate the dispersal of
bacteria from microcolonies and the binding to new sites in the respiratory tract.
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Introduction
 
The expression of virulence by bacterial pathogens often
requires the production and action of toxins and adhesins.
Whereas toxins are generally released by the pathogens into
the extracellular milieu and can thus act at distant sites, ad-
hesins typically remain associated with the bacterial surface,
allowing the microorganisms to adhere to host determi-
nants such as glycolipids, proteoglycans, surface, and matrix
proteins (1–5).
More recently, it has become apparent that some bacte-
rial adhesins are, in part, released from the cell surface into
the extracellular milieu (6–11). However, adhesin release
has essentially been observed in vitro. Whether it has any
relevance for the expression of virulence, or whether it
even takes place in vivo, in apparent contrast with adhesins’
established functions, has not been addressed so far.
To investigate the significance of adhesin release during
bacterial infection, we used 
 
Bordetella pertussis
 
, the whoop-
ing cough agent, as a model. Respiratory epithelial cells
and phagocytic cells are the primary targets for adherence
by 
 
B. pertussis
 
, which produces several adhesins thought to
act synergistically in the colonization of the human respira-
tory tract (12, 13). One of the 
 
B. pertussis
 
 major adhesins,
filamentous hemagglutinin (FHA),
 
*
 
 partitions in vitro be-
tween the cell surface and the extracellular milieu (14–16).
As a multifunctional attachment protein, it has several
ligands, including lactosyl ceramides of ciliated respiratory
cells (17, 18), sulphated sugars at the surface of epithelial
cells and in the extracellular matrix (19), and two leukocyte
integrins (20, 21). In addition, and similar to other adhesins
in many other pathogenic microorganisms, surface-associ-
ated FHA induces auto-agglutination (22).
FHA derives from a 370-kD precursor called FhaB (14)
and corresponds to the NH
 
2
 
-terminal two-thirds of the
precursor. The maturation of FhaB is necessary for extra-
cellular FHA release, and the protease responsible for this
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maturation has been identified recently and named SphB1
(23). SphB1 is a surface protein of the subtilisin superfamily
(24), and the expression of its gene is coordinately regu-
lated with that of the FHA structural gene (25, 26). In
SphB1-deficient bacteria, virtually no FHA is released into
the surrounding milieu, although large amounts of FHA-
related polypeptides are found at the cell surface (23).
To assess the role of FHA release in 
 
B. pertussis
 
 coloniza-
tion, we took advantage of the recently discovered “redun-
dancy” between FHA and pertussis toxin (PTX) in a
mouse model of colonization (27). 
 
B. pertussis
 
 strains lack-
ing either PTX or FHA colonized the mouse respiratory
tract nearly as efficiently as the isogenic parent strain, while
mutants lacking both factors colonized substantially less
well (27). In that model, colonization in the absence of
FHA is not due to the adhesive properties of PTX, but to
its ADP-ribosylation activity, causing a strong inflamma-
tion of the mouse respiratory tract and thus obscuring the
role of FHA (27). In contrast, mutants deficient in PTX
production induce only mild inflammation, and require
FHA for murine respiratory tract colonization. We thus
produced a 
 
B. pertussis
 
 double mutant, deficient for both
SphB1 and PTX. The analysis of this strain in that murine
respiratory model of infection indicated that the maturation
of FhaB and the release of FHA into the extracellular mi-
lieu are necessary for efficient colonization.
 
Materials and Methods
 
Construction of B. pertussis Mutant Strains.
 
The 
 
B. pertussis
 
strains used in this study were derived from BPSM (reference 28;
Table I). BPRA harbors a deletion of the entire 
 
ptx
 
 operon and
BPDR harbors deletions of the entire gene coding for FHA,
 
fhaB,
 
 and of the entire 
 
ptx
 
 operon (27, 29). BPLC6 is a BPRA-
derived 
 
sphB1
 
 null mutant obtained by homologous recombina-
tion (30) as follows. The two gene fragments flanking a 
 
 
 
600 bp
internal region of 
 
sphB1
 
 were inserted into pJQ200mp18
 
rpsL
 
 (31)
as described earlier (23). This construct was used for allelic ex-
change in BPRA, yielding BPLC6. BPLC8 and BPLC9 were ob-
tained by genetic inactivation of the first gene of the 
 
ptx
 
 operon,
 
ptx-S1
 
, with the pFUS2 suicide vector as described previously
(25). The oligonucleotides 5
 
 
 
-TATAAAGCTTAACAGCGC-
TTTCGTCTCCAC-3
 
 
 
 and 5
 
 
 
-TATAGGTACCCATGCAA-
GCGCCTATCACC-3
 
 
 
 were used to amplify the 5
 
 
 
 portion of
the 
 
ptx-S1
 
 gene of the PTX operon. The PCR product was di-
gested by 
 
Hin
 
dIII and 
 
Kpn
 
I and inserted into the same sites of
pFUS2. The resulting vector was used to inactivate the 
 
ptx
 
 op-
eron in BPLC7 (23) and BPLC5 (23) by homologous recombina-
tion, yielding respectively BPLC8 and BPLC9. These strains thus
carry a gentamycin-resistant plasmid stably inserted into 
 
ptx-S1
 
,
with a polar effect on the rest of the operon.
The absence of PTX in culture supernatants was verified by
immunoblotting using antibodies against the S1 subunit of PTX,
as described (23). All 
 
B. pertussis
 
 strains were grown on Bordet-
Gengou agar (BG) or in liquid modified Stainer-Scholte me-
dium as described before (32). The culture media were supple-
mented with 100 
 
 
 
g/ml streptomycin or 10 
 
 
 
g/ml gentamycin
where appropriate.
 
Protein Preparations and Analyses.
 
Proteins were prepared and
analyzed as described (23). A mixture of the anti-FHA monoclonal
antibodies F1, F4, and F5 was used for immunoblotting (23). The
antiserum against SphB1 was described previously (23). FHA was
purified from BPRA culture supernatants as described (33).
 
Flow Cytometry. B. pertussis
 
 cells were prepared as described
(23). The bacterial suspensions were incubated for one hour with
the anti-FHA monoclonal antibodies 55.4G9 or 55.6C4 (34) di-
luted 50-fold in PBS containing 5% glycerol (PBSG). The bacte-
ria were washed three times in PBSG and incubated at room
temperature for 1 h with FITC-conjugated anti–mouse IgG
(Dako) diluted 300-fold in PBSG. After three washes, bacteria-
associated fluorescence was quantified by flow cytometry using
an EPICS Elite cytometer (Beckman Coulter).
 
Cell Adherence Assay.
 
The human pulmonary epithelial cell
line A549 and the murine alveolar macrophage-like cell line
MH-S were cultured as described (27). For 2 d in 24-well plates,
2 
 
 
 
 10
 
5
 
 cells per well were cultured. The bacterial strains were
grown and labeled as described (27). Mammalian cells were
washed once with RPMI 1640 (GIBCO BRL) before the addi-
tion of 4 
 
 
 
 10
 
6 35
 
S-labeled bacteria per well and incubation for
1 h 30 min at 37
 
 
 
C with 5% CO
 
2
 
. After three washes with RPMI
to remove nonadherent bacteria, the mammalian cells were lysed
with 0.5% sodium dodecyl sulfate. Whole lysates were quantified
by liquid scintillation counting. The experiments were performed
three times independently in triplicate.
 
Intranasal Infection of Mice. B.  pertussis
 
 grown on BG agar
plates was suspended in sterile PBS and adjusted to a concentra-
tion of 
 
 
 
5 
 
 
 
 10
 
7
 
 CFU/ml, 5 
 
 
 
 10
 
6
 
 CFU/ml, or 5 
 
 
 
 10
 
5
 
 CFU/
ml depending on the experiments as indicated in the figure leg-
ends. Infections were performed by the intranasal route with 20
 
 
 
l of the bacterial suspensions deposited into the nostrils of
4-wk-old female BALB/c inbred mice (Iffa Credo) lightly anesthe-
tized with a cocktail of physiological water containing 20% (vol/
vol) Imalgen 1000 (Merial), 10% Atropine (Aguettant), and 6%
Valium (Roche), given intraperitoneally (150 
 
 
 
l per 20 g of body
weight; reference 27). This mode of inoculation prevents swal-
lowing of the inoculum, while causing no significant respiratory
compromise (35). At the indicated time points, serial dilutions
from individual lungs were plated onto BG agar, and the num-
bers of CFU were determined after 3 d of incubation at 37
 
 
 
C.
Four BALB/c mice per time point and per group were assessed,
and the experiments were performed at least twice indepen-
dently. All animal studies were performed under the guidelines of
the Institut Pasteur animal study board.
 
Statistical Analysis.
 
The results were analyzed using the un-
paired Student’s 
 
t
 
 test. Differences were considered significant at a
 
P
 
 value of 
 
 
 
0.05 for in vivo experiments and P 
 
 
 
 0.01 for in
vitro experiments.
 
Results
 
Construction and Characterization of B. pertussis Strains.
B. pertussis
 
 strains that differ with respect to the expression
of 
 
fhaB
 
 and 
 
sphB1
 
 were constructed by allelic exchange for
use in a murine respiratory model. All the 
 
B. pertussis
 
 strains
used in this study have a PTX
 
 
 
 phenotype, because this
model allows us to analyze specifically the role of FHA,
which is otherwise obscured by the strong PTX-induced
inflammation (27).
The parental strain, BPRA, both produces cell-associ-
ated FHA and releases substantial amounts of FHA into
the extracellular milieu (Fig. 1, A and B, lane 1), whereas
the FHA-deficient strain BPDR does not (Fig. 1, A and B,T
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lane 2). Both strains produce SphB1 (Fig. 1 C, lanes 1 and
2), and BPRA presents surface-bound FHA, as evidenced
by flow cytometry, whereas BPDR does not (Fig. 1 D, 1
and 2). The 
 
sphB1
 
 null mutant BPLC6 produces no
SphB1 (Fig. 1 C, lane 3) and does not release FHA into
the extracellular milieu (Fig. 1 A, lane 3), although it pro-
duces cell-associated FHA-related polypeptides (Fig. 1 B,
lane 3) that are surface-exposed (Fig. 1 D, 3). Only low
amounts of an FHA-related protein 14 kD larger than
FHA and resulting from an alternative maturation of FhaB
by an undetermined protease (FHA
 
* 
 
in Fig. 1 A, lane 3;
reference 23) were found in culture supernatants of
BPLC6. Similar to BPLC6, BPLC8, which produces inac-
tive SphB1 because of the substitution of the catalytic
serine by an alanine (Ser
 
412
 
→
 
Ala; reference 23), produces
cell-associated FHA-related polypeptides (Fig. 1 B, lane 4)
that are surface-exposed (Fig. 1 D, 4) and only releases
small amounts of FHA
 
* 
 
into the extracellular milieu (Fig.
1 A, lane 4). As SphB1 is responsible for its own pro-
teolytic maturation (23), only the precursor form of
SphB1 was found in the BPLC8 cell extracts (Fig. 1 C,
lane 4).
Similar to BPLC6, BPLC9 produces no SphB1 and has
cell-associated, surface-exposed FHA-related polypeptides
(data not depicted), but in addition it carries a chromo-
somal resistance marker useful in coinfection experiments
(see below). BPRA, BPDR, BPLC6, BPLC8, and BPLC9
do not produce PTX, as evidenced by immunoblotting of
culture supernatants using antibodies against the S1 subunit
of PTX (data not depicted).
The relevant features of the strains are summarized in
Table I. The growth rates in the exponential phase of liq-
uid cultures were similar for all strains, irrespective of the
presence of the gentamycin marker or the SphB1 defect.
 
In Vitro Adherence of the Recombinant Strains.
 
To deter-
mine whether the absence of FhaB maturation affects the
adherence properties of 
 
B. pertussis
 
, we compared the in
vitro attachment of SphB1-deficient bacteria to eukaryotic
cells, with those of FHA
 
 
 
 and FHA
 
 
 
 isogenic strains, using
the human pulmonary epithelial cell line A549 and the
murine alveolar macrophage-like cell line MH-S (Fig. 2).
The absence of FHA significantly affected the adherence of
 
B. pertussis
 
 to both cell lines, as reported previously (27). In
contrast, the absence of SphB1 or the presence of the inac-
tive protease appeared to actually increase the levels of in
vitro attachment relative to those of parental BPRA (FHA
 
 
 
SphB1
 
 
 
), indicating that SphB1-deficient 
 
B. pertussis
 
 pre-
senting FHA-related polypeptides at the cell surface are
competent for adherence to the host cells. Since sur-
face-associated FHA has been shown to induce auto-
agglutination (22), the increased levels of adherence of the
SphB1-deficient strains might reflect the tendency to self-
aggregation of these strains, as was observed in the late ex-
ponential phase of liquid cultures (data not depicted).
Figure 1. Secretion of FHA
and detection of cell-associated
FHA and SphB1 in B. pertussis
parental and mutant strains. (A)
Identical volumes of nonconcen-
trated supernatants from each
culture at the late logarithmic
phase of growth were analyzed
by SDS-PAGE using an 8%
polyacrylamide gel. The gel was
stained with Coomassie Blue.
Only the gel portion corre-
sponding to high molecular
masses is shown. BPRA (FHA 
SphB1 ), BPDR (FHA  SphB1 ),
BPLC6 (FHA  SphB1 ), and
BPLC8 (FHA  S412→A SphB1).
FHA indicates the position of
the mature protein and FHA*
that of a slightly larger FHA-
related polypeptide. (B) Cellular
lysates were subjected to SDS-
PAGE using a 6% polyacryl-
amide gel and immunoblotting
with anti-FHA antibodies. FhaB
and FHA represent the precursor
and mature forms of FHA, re-
spectively. (C) Cellular lysates
were subjected to SDS-PAGE
using an 8% polyacrylamide gel
and immunoblotting with an
anti-SphB1 antiserum. pSphB1 and SphB1 are the precursor and mature forms of the protease SphB1, respectively. (D) BPRA (1), BPDR (2), BPLC6
(3), and BPLC8 (4) were incubated with monoclonal anti-FHA antibodies 55.4G9 (left row) or 55.6.C4 (right row), followed by anti–mouse FITC con-
jugate. The fluorescent cells were detected by flow cytometry, with 20,000 events counted for each sample. The fluorescence threshold (left end of the
horizontal bar) was set such that 98% of nonlabeled cells had intensities of autofluorescence below the threshold value. A representative experiment is
shown, with percentages of fluorescent cells indicated in each panel.T
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Importance of FHA Release for Optimal Colonization by B.
pertussis.
 
To assess the importance of FHA release for col-
onization in a mouse model of infection by 
 
B. pertussis
 
,
mice were infected intranasally with 
 
sphB1
 
 null BPLC6,
with BPLC8, producing enzymatically inactive SphB1, or
with BPRA (FHA
 
 
 
) or BPDR (FHA
 
 
 
) used as controls.
The numbers of CFU present in the lungs were deter-
mined 3 h, 3 d, and 7 d after infection. The lungs were
chosen as endpoint because, compared with the tracheal
colonization, the majority of the bacteria (
 
 
 
90%) were
found in the lungs with this mode of inoculation. After 3 d,
BPRA had multiplied in the lungs, and it persisted at high
numbers for at least 7 d after infection (Fig. 3). In contrast,
BPDR, BPLC6, and BPLC8 had not multiplied at day 3,
and all three were cleared significantly faster than parental
BPRA, as shown by the low numbers of bacteria recovered
at day 7. The low levels of colonization in the absence of
SphB1 or in the presence of inactive SphB1 suggest that
the processing and release of FHA are necessary for optimal
colonization of the mouse lungs by 
 
B. pertussis.
Role of Free FHA in Colonization by B. pertussis.
 
To rule
out the possibility that the colonization defect of the
SphB1-deficient bacteria arises from protease functions
other than FHA maturation, cocolonization experiments
were performed with the following rationale. If, as is the
case for some mucosal pathogens, the protease degrades
host proteins, which may facilitate colonization (36), bacte-
ria producing SphB1 could provide this function and
should thus enhance in trans colonization by protease-
defective bacteria that present FHA-related polypeptides at
their surface. If, on the other hand, it is the release of FHA
 
Table I.
 
Relevant Genotypes and Phenotypes of the B. pertussis Strains Used in this Study and Their Parental Strains
 
Phenotypes
Strains
Parental
strains Genotypes
Released
FHA
Cell-
associated
FHA SphB1 PTX Marker Reference
PTX-proficient strains BPSM
 
     
 
28
BPLC5 BPSM
 
 
 
sphB1
 
     
 
23
BPLC7 BPSM
 
sphB1
 
S412
 
→A    Inactive   23
PTX-deficient strains BPRA BPSM  ptx       29
BPDR BPRA  ptx,  fhaB       27
BPLC6 BPRA  ptx,  sphB1       This study
BPLC8 BPLC7 sphB1S412→A, ptx-S1 :: pFUS2    Inactive   G This study
BPLC9 BPLC5  sphB1, ptx-S1 :: pFUS2       G This study
G, gentamycin resistance cassette.
Figure 2. Adherence of B. pertussis to cell lines in vitro. Human pul-
monary epithelial cells A549 (A) and murine alveolar macrophage-like
MH-S cells (B) were incubated with the indicated 35S-labeled bacteria at a
multiplicity of infection of 20. After washing, adherence was assessed by
scintillation counting. The results are expressed as percentages of counts
per minute relative to the counts per minute present in the inoculum.
Black bars, BPRA, gray bars, BPDR, white bars, BPLC6 and stippled
bars, BPLC8. The data represent averages and standard deviations for trip-
licate experiments. *P   0.01 relative to values obtained for BPRA.
Figure 3. Lung colonization by SphB1 mutant strains. Balb/c mice
were infected intranasally with  105 CFU of B. pertussis BPRA (black
bars), BPLC6 (white bars), BPLC8 (stippled bars), or BPDR (gray bars).
At the indicated time points, mice were killed, and the viable bacteria
present in the lungs were counted. Four mice were analyzed per time
point for each group. *P   0.05 relative to the BPRA values.T
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that contributes to colonization, the addition of exoge-
nously added purified FHA should enhance the coloniza-
tion by protease-deficient bacteria.
Mice were therefore intranasally coinfected with SphB1-
producing, FHA-deficient BPDR and with SphB1-defi-
cient BPLC9, carrying a gentamycin-resistance marker to
distinguish between the two coadministered strains. To
detect a potential enhancing effect of SphB1 in trans, it was
necessary to increase the persistence of BPDR by inoculat-
ing larger numbers. Under these conditions, at least 104
bacteria remained in the respiratory tracts of mice after
several days, even though they did not multiply (Fig. 4,
striped bars). The colonization profile of BPLC9 observed
in coinfected mice was similar to that observed when
BPLC9 was administered alone, as evidenced by the ab-
sence of a multiplication peak at day 3 and significant
clearance by day 7. The SphB1-producing strain BPDR
did thus not enable the protease-deficient bacteria BPLC9
to colonize and multiply in mouse lungs, arguing against
SphB1 having a major impact on colonization through its
proteolytic activity on host tissue in vivo. Thus, SphB1
may instead have a role in the maturation and release of
FHA in vivo.
To confirm the hypothesis that shed FHA may play an
important role in colonization, mice were treated with 5
 g of purified FHA instilled intranasally and then immedi-
ately infected with BPLC6 (SphB1 ). As a control, the
same bacterial suspension was used to infect mice after an
instillation of the same buffer without FHA. 3 d after infec-
tion, the numbers of bacteria recovered from the lungs of
mice pretreated with FHA were 10-fold higher than those
recovered from the lungs of nontreated mice (Fig. 5).
These results indicate that free FHA added exogenously
enhanced the colonization of the mouse respiratory tract by
B. pertussis strains that are unable to release their surface-
associated FHA.
To support the role of free FHA in enhancing coloniza-
tion by SphB1-deficient B. pertussis, mice were coinfected
with BPRA (FHA  SphB1 ) and BPLC9 (FHA  SphB1 ),
carrying a gentamycin-resistance marker. In this experi-
mental setting, physiological amounts of FHA could be re-
leased by BPRA to help BPLC9 colonize. The coinfection
with BPRA resulted in significantly enhanced colonization
by BPLC9 compared with that observed in the absence of
BPRA (Fig. 6). This enhancement was conspicuous 3 d af-
ter infection, when the coinfecting parental strain has mul-
tiplied and secreted FHA. It is likely that the release of
FHA by BPRA during the first days of infection leads to
the dispersal of the bacteria from mixed microcolonies con-
taining both BPRA and BPLC9. This in turn may facilitate
the spread of the mutant bacteria and hence their persis-
tence, as was observed at day 3. These data confirm that the
maturation and release of FHA substantially contribute to
colonization.
Discussion
Bacterial adhesins promote colonization at the initial
stages of an infection by mediating attachment to host tis-
sues, thus avoiding nonspecific host defenses such as me-
chanical clearance and allowing bacterial multiplication to
occur within the host (1). To exert these functions, adhes-
ins need to be presented at the surface of the bacterium.
Like typical adhesins, B. pertussis’ FHA attaches the bacte-
rium to receptors in the respiratory tract (17–21, 28).
However, in addition to being surface-associated, large
amounts of FHA are also released into the extracellular mi-
lieu (15). This has so far only been observed in vitro. In this
work, we show for the first time that FHA is likely to also
be released in vivo, and that its secretion is necessary for ef-
ficient colonization in a mouse model of infection. Our re-
Figure 4. Lung colonization by B. pertussis BPLC9 in coinfection.
Balb/c mice were infected intranasally with  104 CFU of B. pertussis
BPLC9 (SphB1 ; black bars), or coinfected with 104 CFU of B. pertussis
BPLC9 and 106 CFU of B. pertussis BPDR (FHA  SphB1 ). The white
bars represent the numbers of CFU of BPLC9 (as distinguished by their
resistance to gentamycin) in the lungs of coinfected mice, and the striped
bars represent the numbers of BPDR in the coinfected mice.
Figure 5. Effect of an intranasal treatment with FHA on colonization
by BPLC6. Balb/c mice were treated by an intranasal instillation of either
20  l of PBS containing 0.5 M NaCl (PBS/NaCl) and 5  g of purified
FHA or 20  l of PBS/NaCl, and then immediately infected intranasally
with  5   104 CFU of B. pertussis BPLC6 (SphB1 ). At the indicated
time points, mice were killed, and the viable bacteria present in the lungs
were counted. Black bars, numbers of BPLC6 after mock treatment,
white bars, numbers of BPLC6 after the FHA treatment. *P   0.05 rela-
tive to the numbers of BPLC6 CFU administered without FHA.T
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sults support the paradigm that the secreted form of bacte-
rial adhesins may participate in pathogenesis.
The use of B. pertussis strains deficient in FHA release
but presenting FHA polypeptides at their surface has shown
that the maturation and release of FHA are of paramount
importance in vivo. Bacteria that do not release FHA are
defective in their ability to multiply and persist in the lungs
of mice, despite their increased adhesiveness in vitro. This
defect was apparent 3 d after infection, which corresponds
to the peak of multiplication of wild-type bacteria under
the same conditions. These observations indicate that the
lack of FHA maturation and release enhances the clearance
of the bacteria. Surface-associated FHA has been shown to
cause auto-agglutination of B. pertussis (22). The exacerba-
tion of this aggregative phenotype in SphB1-deficient bac-
teria as observed in vitro might be detrimental to coloniza-
tion. Similarly, the highly adherent phenotype of these
bacteria to respiratory cells and their inability to release
FHA may be counter-productive for colonization. There-
fore, a first role of adhesin release may be to facilitate the
dispersal of bacteria from microcolonies and their detach-
ment from epithelial surfaces.
The addition of free FHA or the coadministration of B.
pertussis proficient in FHA release transiently enhanced the
in vivo multiplication and persistence of bacteria that are
unable to release their surface-bound FHA. Their en-
hanced persistence at day 3 is compatible with the notion
of complementation in trans by exogenously added FHA
or after coadministered bacteria had multiplied and secreted
FHA. In the first experiment, exogenously added FHA
may have contributed to the spread of the protease-defi-
cient bacteria by facilitating their binding to the respiratory
tract via homotypic FHA–FHA interactions, while limiting
their aggregation. In the coinfection experiments, the per-
sistence of the SphB1-deficient bacteria was transiently en-
hanced most likely because their dispersal in the respiratory
tract was facilitated by the presence of wild type bacteria.
This is consistent with the fact that in vitro the aggregation
of SphB1-deficient bacteria generally observed in the late
exponential phase of liquid cultures was markedly reduced
in cocultures containing bacteria proficient for FHA re-
lease. In a similar manner, it is possible that mixed bacterial
aggregates formed during the course of infection in vivo
were dissociated by the effect of FHA release by wild-type
bacteria. In a dynamic process such as colonization, the
flexibility afforded by the partitioning of adhesins between
the bacterial surface and the external milieu is an asset to fa-
cilitate the dispersal of bacteria and the spread of the infec-
tion throughout the respiratory tract.
Although the mouse model reproduces certain features
of human whooping cough, such as lymphocytosis, and has
been extensively used in many laboratories to tackle the
pathophysiological issues of pertussis (37), it differs from
the human model by the fact that in mice the infection oc-
curs largely in the lungs, while in humans it is essentially
confined to the upper airways. In spite of this difference, it
is nevertheless possible that the release of FHA by B. pertus-
sis may also promote colonization of the human respiratory
tract by facilitating the dispersal of the bacteria. Unfortu-
nately, this can only be addressed conclusively by human
infection experiments using the FHA release mutants.
The kinetics of adhesin synthesis and the ability to shed
adhesins are likely to both be important during infection.
FHA is among the first adhesins participating in the coloni-
zation by B. pertussis (38). Accordingly, fhaB is among the
first genes to be activated upon a shift from nonvirulent to
virulent growth conditions in vitro (39, 40), and artificially
delayed expression of fhaB by promoter replacement affects
colonization (41). Similarly, it has been suggested that the
time-dependent maturation of FHA may be important (6).
Here, we extend these dynamics to the importance of FHA
release for optimal colonization. Maximal FHA-mediated
adherence may occur when the adhesin is cell-associated,
which might be followed by its subsequent release into the
external milieu to facilitate the detachment of bacteria from
host cells it initially bound to and the spread to the sur-
roundings. This may also be the case for other adhesins, as
has been suggested for Hap of Haemophilus influenzae, a
protein which also mediates both adherence to eukaryotic
epithelial cells and bacterial aggregation during the initial
stages of colonization. This adhesin undergoes auto-cata-
lyzed maturation and release (7), which might facilitate H.
influenzae spreading in the respiratory tract, although this
could only be tested in vitro so far. A variation on this
theme is exemplified by the type IV pili of Neisseria menin-
gitidis and enteropathogenic Escherichia coli, which are re-
sponsible for the initial steps of colonization (42, 43). In
both cases, the progression of the infection requires the loss
of piliation, which is mediated by pilus retraction (42, 43).
In addition to mediating the attachment of bacteria to
host tissues, adhesins, and in particular free adhesins, may
have additional functions in the development of the infec-
tion. They may be biological effectors in vivo and thus in-
fluence the outcome of the host–pathogen interaction
(44). In fact, FHA has recently been shown to affect the
Figure 6. Lung colonization by B. pertussis BPLC9 in coinfection.
Balb/c mice were infected intranasally with  104 CFU of B. pertussis
BPLC9 (SphB1 , black bars), or coinfected with 104 CFU of B. pertussis
BPLC9 and 105 CFU of B. pertussis BPRA (FHA  SphB1 ). The white
bars represent the numbers of CFU of BPLC9 (as distinguished by their
resistance to gentamycin) in the lungs of coinfected mice. *P   0.05 rela-
tive to the number of CFU of BPLC9 administered alone.T
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inflammatory and apoptotic responses (45, 46). Therefore,
the release of certain adhesins by bacterial pathogens may
contribute to infection through activities other than their
strict adhesive functions, the discovery of which may
open the way for new and effective interventions against
infectious diseases.
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